Document is current
Any future updates will be listed below
-
Authors
Shindo, Takero
Shindo, Mami
-
Funding
Funding for this research was provided by:
Meiji Seika Pharma
Hiroshima University
- License Information
-
More Information
Article History
Received: 14 August 2025
Revised: 10 May 2026
Accepted: 12 May 2026
First Online: 27 May 2026
Declarations
:
: T. Shindo received advisory fees from Meiji Seika Pharma Co., Ltd. and lecture fees from Novartis Pharmaceuticals, Johnson and Johnson Innovative Medicine, and Meiji Seika Pharma Co., Ltd. M. Shindo is an employee of Meiji Seika Pharma Co., Ltd., which funded this study.
